Abstract
Although resection can provide long-term survival approaching 20 %, only 20–30 % of newly diagnosed cases of pancreatic adenocarcinoma are amenable to surgical resection and over 50 % of patients have distant disease at presentation. Knowledge of the various palliative operative and non-operative procedures is therefore critical in the multidisciplinary treatment of this disease. Palliative care for pancreas cancer encompasses a large number of medical, procedural, and surgical interventions that have evolved over the years. There are several surgical interventions available; some prophylactic and others designed for symptomatic relief. It is important to understand their benefits, applicability, and outcomes when compared to less invasive procedures.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Werner J, Combs SE, Springfiled C, et al. Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol. 2013;10(6):323–33.
Ahrendt SA, Pitt HA. Surgical management of pancreatic cancer. Oncology. 2001;16(6):725–34.
Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350(12):1200–10.
Singh SM, Longmire WP, Reber HA. Surgical palliation for pancreatic cancer. The UCLA experience. Ann Surg. 1990;212(2):132–9.
House MG, Lillemoe KD. Palliative therapy for pancreatic cancer. In: Cameron JL, editor. Current surgical therapy. 8th ed. St Louis, MO: Mosby Inc; 2004. p. 504–10.
Kuhlmann KF, de Castro SM, Wesseling JG, et al. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer. 2004;40:549–58.
Boyd AD, Riba M. Depression and pancreatic cancer. J Natl Compr Canc Netw. 2007;5:113–6.
Ottery F. Supportive nutritional management of the patient with pancreatic cancer. Oncology (Williston Park). 1996;10:26–32.
Cote GA, Sherman S. Endoscopic palliation of pancreatic cancer. Cancer J. 2012;18(6):584–90.
Moss AC, Morris E, Leyden J, et al. Malignant distal biliary obstruction; a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev. 2007;33(2):213–21.
Moss AC, Morris E, Leyden J, et al. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trails comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol. 2007;12(12):1119–24.
Bornan PC, Harries-Jones EP, Tobias R, et al. Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. Lancet. 1986;1(8472):69–71.
Shepard HA, Royle G, Ross AP, et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg. 1988;75(12):1166–8.
Smith AC, Dowsett JF, Russell RC, et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet. 1994;344(8938):1655–60.
Artifon EL, Sakai P, Cunha JE, et al. Surgery or endoscopy for palliation of biliary obstruction due to metastatic pancreatic cancer. Am J Gastroenterol. 2006;101(9):2031–7.
Qadan M, Clarke S, Morrow E. et al. Sump syndrome as a complication of choledochoduodenostomy. Dig Dis Sci. 2012;57(8):2011–5.
Urbach DR, Bell CM, Swanstrom LL, et al. Cohort study o surgical bypass to the gallbladder or bile duct for the palliation of jaundice due to pancreatic cancer. Ann Surg. 2003;237(1):86–93.
Toumi Z, Aljarabah M, Ammori BJ. Role of laparoscopic approach to biliary bypass for benign and malignant biliary diseases: a systematic review. Surg Endosc. 2011;25(7):2105–16.
Rothlin MA, Schob O, Weber M. Laparoscopic gastro- and hepaticojejunostomy for palliation of pancreatic cancer: a case controlled study. Surg Endosc. 1999;13(11):1065–7069.
Conrad C, Lillemoe KD. Surgical palliation of pancreatic cancer. Cancer J. 2012;18(6):577–83.
Fiori E, Lamazza A, Volpino P, et al. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res. 2004;24(1):269–71.
Khashab M, Alawad AS, Shin EJ, et al. Enteral stenting versus gastrojejunostomy for palliation of malignant gastric outlet obstruction. Surg Endosc. 2013;27:2068–75.
Mehta S, Hindmarsh A, Cheong E, et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc. 2006;20(2):239–42.
Jeurnink SM, Steyerberg EW, van Hooft JE, et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc. 2010;71(3):490–9.
No JH, Kim AW, Lim CH, et al. Long-term outcome of palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer in patients with very good performance status: endoscopic stenting versus surgery. Gastrointest Endosc. 2013;78(1):55–62.
Laval G, Avieux C, Stefani L, et al. Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Gernoble University Hospital Center. J Pain Symptom Mange. 2006;31(6):502–12.
Brookbank MA, Gane PA, Ashby MA. Palliative venting gastrostomy in malignant intestinal obstruction. Palliat Med. 2002;1(6):520–6.
Sialis AM, Pearce LF, Lestina LS, et al. Percutaneous radiologic gastrostomy/jejunostomy (PEG/PEJ) for decompression in the upper gastrointestinal tract. Initial experience with palliative treatment of gastrointestinal obstruction of terminally ill patients with advanced carcinomas. Surg Endosc. 1999;13(11):1103–5.
Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg. 1999;230(3):322–8.
Van Heek NT, De Castro SM, van Eijck CH, et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg. 2003;238(6):894–902.
Nikfarjam M, Kimchi ET, Gusani NJ, et al. A reduction in delayed gastric emptying by classic pancreaticoduodenectomy with an antecolic gastrojejunal anastomosis and a retrogastric omental patch. J Gastrointest Surg. 2009;13:1674–82.
Hatel M, Wente MN, Hinz U, et al. Effect of antecolic reconstruction on delayed gastric emptying after the pylorus-preserving Whipple procedure. Arch Surg. 2005;140:1094–9.
Kuraha H, Shinchi H, Maemura K, et al. Delayed gastric emptying after pancreaticoduodenectomy. J Surg Res. 2011;171:187–92.
Gangavatiker R, Pal S, Javed A, et al. Effect of antecolic or retrocolic reconstruction of the gastro/duodenojejunostomy on delayed gastric emptying after pancreaticoduodenectomy: a randomized controlled trial. J Gastrointest Surg. 2011;15:843–52.
Imamura N, Chijiiwa K, Ohuchida J, et al. Prospective randomized clinical trial of a change in gastric emptying and nutritional status after a pylorus-preserving pancreaticoduodenectomy: comparison between an antecolic and a vertical antecolic duodenojejunostomy. HPB. 2014;16:384–94.
Eshuis WJ, van Eijck CH, Gerhards MF, et al. Antecolic versus retrocolic route of the gastroenteric anastomosis after pancreaticoduodenectomy: a randomized controlled trial. Ann Surg. 2014;259(1):45–51.
Sahora K, Morales-Oyarvide V, Thayer SP, et al. The effect of antecolic versus retrocolic reconstruction on delayed gastric emptying after classic non-pylorus-preserving pancreaticoduodenectomy. Am J Surg. 2015;209(6):1028–35.
House MG, Choti MA. Palliative therapy for pancreatic/biliary cancer. Surg Oncol Clin N Am. 2004;13:491–503.
Arcidiacono PG, Calori G, Carrara S, et al. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev. 2011;3, CD007519.
Fabbri C, Luigiano C, Lisoti A, et al. Endoscopic ultrasound-guided treatments: are we getting evidence based—a systemic review. World J Gastroenterol. 2014;20(26):8424–48.
Lillemoe KD, Cameron JL, Kaufman HS, et al. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg. 1993;217(5):447–57.
Allen P, Chou J, Janakos M. Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma. Ann Surg Oncol. 2011;18:636–41.
Martin R, Philips P, Ellis S, et al. Irreversible electroporation of unresectable soft tissue tumors with vascular invasion: effective palliation. BMC Cancer. 2014;14(1):540.
Martin R, McFarland K, Ellis S, et al. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol. 2013;20:S443–9.
Lillemoe KD, Cameron JL, Yeo CJ, et al. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg. 1996;223:718–28.
Gillen S, Schuster T, Friess H, et al. Palliative resections versus palliative bypass procedures in pancreatic cancer—a systemic review. Am J Surg. 2012;203(4):496–502.
Walter J, Nier A, Rose T, et al. Palliative partial pancreaticoduodenectomy impairs quality of life compared to bypass surgery in patients with advanced adenocarcinoma of the pancreatic head. Eur J Surg Oncol. 2011;37(9):798–804.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ismael, H., Badgwell, B. (2016). Palliative Operations for Unresectable Pancreatic Cancer. In: Katz, M., Ahmad, S. (eds) Multimodality Management of Borderline Resectable Pancreatic Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-22780-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-22780-1_20
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22779-5
Online ISBN: 978-3-319-22780-1
eBook Packages: MedicineMedicine (R0)